Methods to avoid infections in patients with inflammatory bowel disease.
Infections have been reported in patients with inflammatory bowel disease (IBD), especially in association with anti-inflammatory and immunomodulatory medications used to treat IBD. Unfortunately, there is a dearth of information on infectious complication risk in patients with IBD. This review describes infectious complications reported in patients with IBD and provides a framework for future studies to assess potential risk factors and incidence for infection. Recommendations are also provided for prevention of infection.
Division of Gastroenterology, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. Faten.aberra@uphs.upenn.edu
Faten N
FN
Aberra
Gary R
GR
Lichtenstein
D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D015984:Causality; D003140:Communicable Disease Control; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007239:Infections / Q000209:etiology*; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000188:drug therapy; D009894:Opportunistic Infections / Q000209:etiology / Q000517:prevention & control*
D000893:Anti-Inflammatory Agents; D007155:Immunologic Factors; D007166:Immunosuppressive Agents